Faricimab demonstrated noninferior vision gains and improved anatomical outcomes among patients with diabetic macular edema ...

Up to 50 transplant patients will receive a genetically modified pig kidney in a clinical trial that will launch this summer ...

From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, ...

The tech giant is set to report earnings as AI spending faces scrutiny. Here's what to expect.

Boehringer Ingelheim’s lung disease drug nerandomilast has been successful in a Phase III study paving the way for the ...

Qureight Ltd, the Core Imaging Laboratory developing deep-learning image analytics, and Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on developing inhaled therapies to treat ...

I can tell you that VDPHL01 has a unique profile unlike current FDA-approved treatments, which are associated with cardiac ...

2 new ACLF clinical trials expected to initiate in 1Q25 3 clinical data readouts expected by year-end 2025 across the ACLF pipeline, including on-going UNVEIL-IT® Phase 2 trial Data of on-going Phase ...

Amgen AMGN reported fourth-quarter 2024 adjusted earnings of $5.31 per share, which beat the Zacks Consensus Estimate of $5.03 per share. Earnings rose 13% year over year as higher revenues were ...

The discovery and development of GLP-1 receptor agonists for type 2 diabetes and obesity is a bench-to-bedside success story.1 Multiple GLP-1 receptor agonists are now in clinical use, such as ...

People who try the Dukan Diet can expect to take a daily helping of oat bran and follow their progress through four "phases": attack, cruise, consolidation, and stabilisation. Healthline writes ...